QT Imaging Holdings, Inc. (QTI) CPT Code 1079T Becomes Effective Earlier
QT Imaging (QTI) announced that CPT code 1079T for its 3D breast acoustic imaging became effective Oct. 1, 2026, three months earlier than expected. This allows the company to begin implementation work with providers and payers sooner, supporting its commercialization efforts.
How this was made
The 30-second read
Why it matters
The milestone could unlock reimbursement pathways, supporting revenue growth and investor sentiment.
Market read
First disclosure of an earlier CPT code effective date, offering a modest but material catalyst for the micro‑cap stock.
What to watch
Potential delays in payer coverage decisions could temper short‑term price reaction.
Background
QT Imaging announced the earlier effective date of its CPT code, a key step toward commercial rollout of its breast imaging platform.
Ticker impact
CPT Category III code 1079T for QT Imaging's 3D breast acoustic imaging became effective Oct 1, 2026, three months earlier than expected.
upward pressure as market prices in the reimbursement milestone.
The code enables immediate implementation with providers and payers, a material commercial catalyst for a micro‑cap biotech.
Market effects
May improve outlook for breast imaging and diagnostic equipment sector.
Limited to U.S. healthcare reimbursement environment.
Minimal global impact; primarily affects QT Imaging.
Counterpoint
Early code adoption may not translate to immediate volume without payer contracts.
Key entities
- CompanyQT Imaging Holdings, Inc.
Developer of 3D breast acoustic imaging technology.
